Search

Your search keyword '"Baborie, A."' showing total 303 results

Search Constraints

Start Over You searched for: Author "Baborie, A." Remove constraint Author: "Baborie, A."
303 results on '"Baborie, A."'

Search Results

1. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

2. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

3. Protein network analysis reveals selectively vulnerable regions and biological processes in FTD

4. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

5. Frontotemporal dementia and its subtypes: a genome-wide association study

7. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

9. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimerʼs and Parkinsonʼs diseases

10. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

11. Muscle biopsy: what and why and when?

12. Exploring Links Between Psychosis and Frontotemporal Dementia Using Multimodal Machine Learning: Dementia Praecox Revisited

13. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

14. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

16. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

17. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

20. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

22. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations

23. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

24. Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors

25. Correction to:A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

26. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

28. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

29. Elderly Individuals With FTLD

40. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

41. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

42. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

45. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP

46. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia

47. Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

48. CXCR4involvement in neurodegenerative diseases

50. Emperipolesis in eosinophilic granuloma of the skull

Catalog

Books, media, physical & digital resources